Novo Nordisk A/SNVONYSE
Loading
Debt to Equity Over TimeElevated
Percentile Rank93
3Y CAGR+29.8%
5Y CAGR+32.8%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
+29.8%/yr
vs +136.1%/yr prior
5Y CAGR
+32.8%/yr
Recent deceleration
Acceleration
-106.4pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
4.1x
Strong expansion
Streak
1 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.67 | -5.8% |
| 2024 | 0.72 | +182.7% |
| 2023 | 0.25 | -17.9% |
| 2022 | 0.31 | -18.0% |
| 2021 | 0.38 | +130.3% |
| 2020 | 0.16 | +110.1% |
| 2019 | 0.08 | +683.5% |
| 2018 | 0.01 | -70.8% |
| 2017 | 0.03 | +572.2% |
| 2016 | 0.01 | - |